abstract |
The present invention relates to an immunoglobulin glycoprotein composition having the predominant glycoform structure of an immunoglobulin glycoprotein that confers specific effector functions. In addition, the present invention relates to a pharmaceutical composition comprising an antibody having a specific enriched N-glycan structure, wherein the N-glycan structure is Gal 2 GlcNAc 2 Man 3 GlcNAc 2 lacking fucose. |